Delivery of cisplatin and resiquimod in nanomicelles for the chemoimmunotherapy of ovarian cancer
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-6966
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Delivery of cisplatin and resiquimod in nanomicelles for the chemoimmunotherapy of ovarian cancer ; volume:13 ; number:1 ; day:7 ; month:3 ; year:2022 ; pages:1-17 ; date:12.2022
Cancer nanotechnology ; 13, Heft 1 (7.3.2022), 1-17, 12.2022
- Creator
-
Yin, Wen
Qian, Sumin
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12645-021-00094-8
- URN
-
urn:nbn:de:101:1-2022060219590423914697
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yin, Wen
- Qian, Sumin
- SpringerLink (Online service)
Other Objects (12)
Engineering Bifunctional Calcium Alendronate Gene‐Delivery Nanoneedle for Synergistic Chemo/Immuno‐Therapy Against HER2 Positive Ovarian Cancer
A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer
Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin
Ovarian vein thrombosis after delivery
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
Role of Purinergic Ligands to Enhance Cisplatin Sensitivity in Ovarian Cancer Cells
Engineering Bifunctional Calcium Alendronate Gene‐Delivery Nanoneedle for Synergistic Chemo/Immuno‐Therapy Against HER2 Positive Ovarian Cancer
A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer
Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin
Ovarian vein thrombosis after delivery
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids
Role of Purinergic Ligands to Enhance Cisplatin Sensitivity in Ovarian Cancer Cells
Engineering Bifunctional Calcium Alendronate Gene‐Delivery Nanoneedle for Synergistic Chemo/Immuno‐Therapy Against HER2 Positive Ovarian Cancer
A Review on Nano-Based Drug Delivery System for Cancer Chemoimmunotherapy
MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer
A phase 2 study of combined chemo-immunotherapy with cisplatin-pembrolizumab and radiation for unresectable vulvar squamous cell carcinoma
Alleviation of endoplasmic reticulum stress protects against cisplatin-induced ovarian damage
Mifepristone prevents repopulation of ovarian cancer cells escaping cisplatin-paclitaxel therapy
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancer
Tumor vasculature remolding by thalidomide increases delivery and efficacy of cisplatin
Ovarian vein thrombosis after delivery
ADAM17 Inhibition Increases the Impact of Cisplatin Treatment in Ovarian Cancer Spheroids